Coley's toxins (English Wikipedia)

Göhring, E (1985). "Fiebertherapie bei Krebs vernachlässigt" (PDF). Ärztl. Praxis. 86: 3377. Archived from the original (PDF) on 2014-05-17. Retrieved 2014-05-16.

archive.org

[1] Pick, Thomas Pickering, "Surgery," Longmans, Green and Company, 1899, Pages 250–251. Retrieved August 3, 2010.
Hall, Stephen K. (1997). A commotion in the blood: life, death, and the immune system. New York: Henry Holt. ISBN 0-8050-5841-9.

bmjjournals.com

pmj.bmjjournals.com

Hoption Cann S, van Netten J, van Netten C (2003). "Dr William Coley and tumour regression: a place in history or in the future". Postgrad Med J. 79 (938): 672–80. doi:10.1093/postgradmedj/79.938.672. PMC 1742910. PMID 14707241. link

cancer.org

"Coley Toxins". American Cancer Society. 1 November 2008. Archived from the original on 26 April 2015. Retrieved 14 April 2014.

cancerresearchuk.org

about-cancer.cancerresearchuk.org

"What is Coley's toxins treatment for cancer?". Cancer Research UK. 22 August 2012. Archived from the original on 17 December 2019.

doi.org

Thotathil Z, Jameson MB (2007). "Early experience with novel immunomodulators for cancer treatment". Expert Opinion on Investigational Drugs. 16 (9): 1391–403. doi:10.1517/13543784.16.9.1391. PMID 17714025. S2CID 33668239.
Kucerova P, Cervinkova M (2016). "Spontaneous regression of tumour and the role of microbial infection – possibilities for cancer treatment". Anticancer Drugs. 27 (4): 269–77. doi:10.1097/CAD.0000000000000337. PMC 4777220. PMID 26813865.
Jessy T (2011). "Immunity over inability: The spontaneous regression of cancer". J Nat Sci Biol Med. 2 (1): 43–9. doi:10.4103/0976-9668.82318. PMC 3312698. PMID 22470233.
Kienle GS (2012). "Fever in Cancer Treatment: Coley's Therapy and Epidemiologic Observations". Glob Adv Health Med. 1 (1): 92–100. doi:10.7453/gahmj.2012.1.1.016. PMC 3833486. PMID 24278806.
Gresser I (1987). "A. Chekhov, M.D., and Coley's toxins". N. Engl. J. Med. 317 (7): 457. doi:10.1056/NEJM198708133170716. PMID 3302707.
Hoption Cann S, van Netten J, van Netten C (2003). "Dr William Coley and tumour regression: a place in history or in the future". Postgrad Med J. 79 (938): 672–80. doi:10.1093/postgradmedj/79.938.672. PMC 1742910. PMID 14707241. link
Tsung K, Norton JA (2006). "Lessons from Coley's Toxin". Surgical Oncology. 15 (1): 25–8. doi:10.1016/j.suronc.2006.05.002. PMID 16814541.
Zacharski L, Sukhatme V (2005). "Coley's toxin revisited: immunotherapy or plasminogen activator therapy of cancer?". J Thromb Haemost. 3 (3): 424–7. doi:10.1111/j.1538-7836.2005.01110.x. PMID 15748226. S2CID 37089721.
Haux J (2001). "Infection and cancer". Lancet. 358 (9276): 155–6. doi:10.1016/S0140-6736(01)05369-7. PMID 11469250. S2CID 26865958.

fh-giessen.de

bioinfo.tg.fh-giessen.de

Hobohm, U.: [2] Archived 2009-12-11 at the Wayback Machine Fever and cancer in perspective, Cancer Immunol Immunother 2001) 50: 391–396 10.1007/s002620100216
Hobohm, U.: [3] Archived 2009-12-11 at the Wayback Machine Fever therapy revisited, British Journal of Cancer (2005) 92, 421 – 425

findarticles.com

"Coley's Toxins – The First Century Townsend Letter for Doctors and Patients – Find Articles". Townsend Letter for Doctors and Patients. 2004. Retrieved 2007-11-10.

ibiotherapy.com

"Coley's Toxins Cancer Treatment". Retrieved 2023-04-11.

landesbioscience.com

Kleef, Ralf; Hager, E. Dieter (2006-09-15). "Fever, Pyrogens and cancer". Landes Bioscience: Curie. Landes Bioscience. Retrieved 2014-10-10.

latimes.com

articles.latimes.com

Germs As A Tumor Foe?^{[dead link]}, from the Los Angeles Times, published February 18, 2008. Accessed March 26, 2008.

latimes.com

Borrell, Brendan (2008-02-18). "Cancer and the bacterial connection". The Los Angeles Times. Retrieved 2008-02-17.

news-medical.net

news-medical.net: Pfizer to acquire Coley Pharmaceutical Group, 19 November 2007

nih.gov

pubmed.ncbi.nlm.nih.gov

Thotathil Z, Jameson MB (2007). "Early experience with novel immunomodulators for cancer treatment". Expert Opinion on Investigational Drugs. 16 (9): 1391–403. doi:10.1517/13543784.16.9.1391. PMID 17714025. S2CID 33668239.
Taniguchi Y, Nishizawa T, Kouhchi C, et al. (2006). "Identification and characterization of lipopolysaccharide in acetic acid bacteria". Anticancer Res. 26 (6A): 3997–4002. PMID 17195448.
Kucerova P, Cervinkova M (2016). "Spontaneous regression of tumour and the role of microbial infection – possibilities for cancer treatment". Anticancer Drugs. 27 (4): 269–77. doi:10.1097/CAD.0000000000000337. PMC 4777220. PMID 26813865.
Jessy T (2011). "Immunity over inability: The spontaneous regression of cancer". J Nat Sci Biol Med. 2 (1): 43–9. doi:10.4103/0976-9668.82318. PMC 3312698. PMID 22470233.
Kienle GS (2012). "Fever in Cancer Treatment: Coley's Therapy and Epidemiologic Observations". Glob Adv Health Med. 1 (1): 92–100. doi:10.7453/gahmj.2012.1.1.016. PMC 3833486. PMID 24278806.
Gresser I (1987). "A. Chekhov, M.D., and Coley's toxins". N. Engl. J. Med. 317 (7): 457. doi:10.1056/NEJM198708133170716. PMID 3302707.
McCarthy EF (2006). "The Toxins of William B. Coley and the Treatment of Bone and Soft-Tissue Sarcomas". The Iowa Orthopaedic Journal. 26: 154–8. PMC 1888599. PMID 16789469.
Hoption Cann S, van Netten J, van Netten C (2003). "Dr William Coley and tumour regression: a place in history or in the future". Postgrad Med J. 79 (938): 672–80. doi:10.1093/postgradmedj/79.938.672. PMC 1742910. PMID 14707241. link
Tsung K, Norton JA (2006). "Lessons from Coley's Toxin". Surgical Oncology. 15 (1): 25–8. doi:10.1016/j.suronc.2006.05.002. PMID 16814541.
Zacharski L, Sukhatme V (2005). "Coley's toxin revisited: immunotherapy or plasminogen activator therapy of cancer?". J Thromb Haemost. 3 (3): 424–7. doi:10.1111/j.1538-7836.2005.01110.x. PMID 15748226. S2CID 37089721.
Haux J (2001). "Infection and cancer". Lancet. 358 (9276): 155–6. doi:10.1016/S0140-6736(01)05369-7. PMID 11469250. S2CID 26865958.
Hussein EA, el Dorri A (1993). "Intra-arterial streptokinase as adjuvant therapy for complicated Buerger's disease: early trials". International Surgery. 78 (1): 54–8. PMID 8473086.
McCarthy, EF (2006). "The Toxins of William B. Coley and the Treatment of Bone and Soft-Tissue Sarcomas". The Iowa Orthopaedic Journal. 26: 154–8. PMC 1888599. PMID 16789469.

ncbi.nlm.nih.gov

Kucerova P, Cervinkova M (2016). "Spontaneous regression of tumour and the role of microbial infection – possibilities for cancer treatment". Anticancer Drugs. 27 (4): 269–77. doi:10.1097/CAD.0000000000000337. PMC 4777220. PMID 26813865.
Jessy T (2011). "Immunity over inability: The spontaneous regression of cancer". J Nat Sci Biol Med. 2 (1): 43–9. doi:10.4103/0976-9668.82318. PMC 3312698. PMID 22470233.
Kienle GS (2012). "Fever in Cancer Treatment: Coley's Therapy and Epidemiologic Observations". Glob Adv Health Med. 1 (1): 92–100. doi:10.7453/gahmj.2012.1.1.016. PMC 3833486. PMID 24278806.
McCarthy EF (2006). "The Toxins of William B. Coley and the Treatment of Bone and Soft-Tissue Sarcomas". The Iowa Orthopaedic Journal. 26: 154–8. PMC 1888599. PMID 16789469.
"History and Background". Retrieved 2007-11-10.
Hoption Cann S, van Netten J, van Netten C (2003). "Dr William Coley and tumour regression: a place in history or in the future". Postgrad Med J. 79 (938): 672–80. doi:10.1093/postgradmedj/79.938.672. PMC 1742910. PMID 14707241. link
"Proposed Mechanism of Action". Retrieved 2007-11-10.
McCarthy, EF (2006). "The Toxins of William B. Coley and the Treatment of Bone and Soft-Tissue Sarcomas". The Iowa Orthopaedic Journal. 26: 154–8. PMC 1888599. PMID 16789469.

nytimes.com

"A Commotion in the Blood". The New York Times. Retrieved 2007-11-10.
New York Times: article on Pfizer and Coley Pharmaceutical Group, 5 October 2005

semanticscholar.org

api.semanticscholar.org

Thotathil Z, Jameson MB (2007). "Early experience with novel immunomodulators for cancer treatment". Expert Opinion on Investigational Drugs. 16 (9): 1391–403. doi:10.1517/13543784.16.9.1391. PMID 17714025. S2CID 33668239.
Zacharski L, Sukhatme V (2005). "Coley's toxin revisited: immunotherapy or plasminogen activator therapy of cancer?". J Thromb Haemost. 3 (3): 424–7. doi:10.1111/j.1538-7836.2005.01110.x. PMID 15748226. S2CID 37089721.
Haux J (2001). "Infection and cancer". Lancet. 358 (9276): 155–6. doi:10.1016/S0140-6736(01)05369-7. PMID 11469250. S2CID 26865958.

waisbrenclinic.com

"Waisbren Clinic – Home Page". Archived from the original on 2007-10-12. Retrieved 2007-11-10.

web.archive.org

"What is Coley's toxins treatment for cancer?". Cancer Research UK. 22 August 2012. Archived from the original on 17 December 2019.
Hobohm, U.: [2] Archived 2009-12-11 at the Wayback Machine Fever and cancer in perspective, Cancer Immunol Immunother 2001) 50: 391–396 10.1007/s002620100216
"Coley Toxins". American Cancer Society. 1 November 2008. Archived from the original on 26 April 2015. Retrieved 14 April 2014.
Hobohm, U.: [3] Archived 2009-12-11 at the Wayback Machine Fever therapy revisited, British Journal of Cancer (2005) 92, 421 – 425
"Waisbren Clinic – Home Page". Archived from the original on 2007-10-12. Retrieved 2007-11-10.
Göhring, E (1985). "Fiebertherapie bei Krebs vernachlässigt" (PDF). Ärztl. Praxis. 86: 3377. Archived from the original (PDF) on 2014-05-17. Retrieved 2014-05-16.